healthcare policy Archives

European Drug Pricing Dispute Escalates Over US Deals

European drug pricing dispute heats up as pharma giants demand higher returns after US price cuts. Tensions are on the rise.

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

2025 Health in Review: Challenges and Triumphs

Dive into the 2025 Health in Review, reflecting on South Africa's healthcare struggles and clinical successes in HIV and TB treatment.

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

1.4% SEP Increase Impacts Pharmaceutical Investment

Understanding the 1.4% SEP increase: why the pharmaceutical sector is urging a reconsideration of the price cap.

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

Competency-Based Medical Curriculum: A Critical Review

SAMA warns about the risks of the WHO competency-based medical curriculum. Discover its implications for medical training and patient safety.

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

BHF Seeks Clarity for Medical Tax Credit Changes

BHF calls for urgent clarity from Treasury on plans to cut medical tax credits that may affect NHI funding and millions of patients.

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

Sakeliga Mounts Legal Challenge Over Health Minister’s Actions

Explore how Sakeliga has mounted a legal challenge to prevent the suspension of constitutional cases regarding the NHI Act.

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

Pharmacists Prescribe HIV Treatment and Enhance Care

Find out how trained pharmacists can now prescribe HIV treatment, revolutionizing access to antiretroviral therapy for patients.

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

FDA Generic Drug Review Boosts US Drug Manufacturing

The US Food and Drug Administration (FDA) has announced the launch of a new pilot programme. This programme aims to accelerate the review process for generic drugs. Companies research, develop, and manufacture these drugs entirely within the United States…. Membership Required You must be a member to access this content.View Membership LevelsAlready a member? Log...